Inhalable liquid formulations of DNase I

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9603906
SERIAL NO

14375439

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

An inhalable pharmaceutical composition for pulmonary administration comprising human DNase I and a liquid carrier and, more particularly, but not exclusively, to methods, liquid pharmaceutical inhalation devices and systems for the therapeutic use thereof are provided.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
PROTALIX LTD2010000 CARMIEL

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Fux, Liat Kiryat-Motzkin, IL 6 15
Hanania, Uri Carmiel, IL 14 30
Kizhner, Tali Yishuv Atzmon-Segev, IL 16 58
Matiuhin, Yulia Pardes Chana-Karkur, IL 5 11
Shaaltiel, Yoseph Timrat, IL 43 445
Shulman, Avidor Rakefet, IL 56 626

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 28, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00